A Pan-Canadian Practice Guideline and Algorithm: Screening, Assessment, and Supportive Care of Adults with Cancer-Related Fatigue

Howell, Doris; Keller-Olaman, Sue; Oliver, Thomas K.; Hack, Thomas F.; Broadfield, Larry; Biggs, Karen; Chung, Joanna; Gravelle, Debbie; Green, E.; Hamel, Marc; Harth, Tamara; Johnston, Pam; McLeod, Deborah; Swinton, Nelda; Syme, Ann; Olson, Kärin

doi:10.3747/co.20.1302

Cited by 165 publications

(162 citation statements)

References 46 publications

(75 reference statements)

Supporting

Mentioning

147

Contrasting

Unclassified

Order By: Relevance

“…[12][13][14][15] Recognizing the negative consequences of psychological distress, professional oncologic societies have begun developing guidelines regarding the assessments and care of patients with cancer who are experiencing distress. 9,16,17 Guidelines include periodic assessments across the trajectory of cancer care, and institutional and community resources for treatment. Integrated multicomponent, collaborative depression care is effective and improves QOL and role functioning in patients with cancer.…”

Section: Introductionmentioning

confidence: 99%

Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment

Sullivan

Forsberg

Ganzini

et al. 2016

JCO

113

104

View full text Add to dashboard Cite

Purpose Depression symptoms are common among patients with lung cancer; however, longitudinal changes and their impact on survival are understudied. Methods This was a prospective, observational study from the Cancer Care Outcomes Research and Surveillance Consortium from five US geographically defined regions from September 2003 through December 2005. Patients enrolled within 3 months of their lung cancer diagnosis were eligible. The eight-item Center for Epidemiologic Studies Depression scale was administered at diagnosis and 12 months’ follow-up. The main outcome was survival, which was evaluated using Kaplan-Meyer curves and adjusted Cox proportional hazards modeling. Results Among 1,790 participants, 681 (38%) had depression symptoms at baseline and an additional 105 (14%) developed new-onset depression symptoms during treatment. At baseline, depression symptoms were associated with increased mortality (hazard ratio [HR], 1.17; 95% CI, 1.03 to 1.32; P = .01). Participants were classified into the following four groups based on longitudinal changes in depression symptoms from baseline to follow-up: never depression symptoms (n = 640), new-onset depression symptoms (n = 105), depression symptom remission (n = 156), and persistent depression symptoms (n = 254) and HRs were calculated. Using the never-depression symptoms group as a reference group, HRs were as follows: new-onset depression symptoms, 1.50 (95% CI, 1.12 to 2.01; P = .006); depression symptom remission, 1.02 (95% CI, 0.79 to 1.31; P = .89), and persistent depression symptoms, 1.42 (95% CI, 1.15 to 1.75; P = .001). At baseline, depression symptoms were associated with increased mortality among participants with early-stage disease (stages I and II; HR, 1.61; 95% CI, 1.26 to 2.04), but not late-stage disease (stages III and IV; HR, 1.05; 95% CI, 0.91 to 1.22). At follow-up, depression symptoms were associated with increased mortality among participants with early-stage disease (HR, 1.71; 95% CI, 1.27 to 2.31) and those with late-stage disease (HR, 1.32; 95% CI, 1.04 to 1.69). Conclusion Among patients with lung cancer, longitudinal changes in depression symptoms are associated with differences in mortality, particularly among patients with early-stage disease. Symptom remission is associated with a similar mortality rate as never having had depression.

show abstract

Section: Introductionmentioning

confidence: 99%

Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment

Sullivan

Forsberg

Ganzini

et al. 2016

JCO

113

104

View full text Add to dashboard Cite

show abstract

“…The article is based on international guidelines for evaluating chronic fatigue in adult cancer survivors (7,8,10), a subjective selection of the relevant literature, and the authors' own clinical experience and research.…”

Section: Methodsmentioning

confidence: 99%

“…Advice on energy conservation by adjusting activity levels to one's perceived level of energy might also be helpful to avoid fluctuations, and possibly help to gradually increase physical capacity. For all those affected it is recommended to maintain a regular circadian rhythm and to avoid sleeping during daytime (7,8).…”

Section: Interventionsmentioning

confidence: 99%

“…Cancer-related fatigue can be defined as a subjective feeling of tiredness, weakness or lack of energy (6) or as an exhausting, persistent subjective sense of physical, emotional and/or cognitive tiredness that is disproportionate to the level of activity (7,8). Even though fatigue is also a cardinal symptom of myalgic encephalomyelitis (ME), ME is defined by the presence of additional symptoms, e.g.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Kronisk tretthet hos voksne kreftoverlevere

Reinertsen¹,

Loge²,

Brekke³

et al. 2017

Tidsskriftet

View full text Add to dashboard Cite

“…In addition, chemotherapy, radiation, and many of the newer targeted therapies (e.g., everolimus) can contribute to ongoing fatigue (Baselga et al 2012 ). Although physical activity may be effective in relieving cancerrelated fatigue in patients with less tumor burden, in patients with metastatic disease, some balance of energy conservation and physical activity may be the most appropriate strategy (Howell et al 2013 ). CAM therapies such as yoga and Tai chi may be effective, but may have to be done cautiously in the setting of bone metastases.…”

Section: The Metastatic Disease Experience and Consequences Of Long-tmentioning

confidence: 99%

Living with Metastatic Breast Cancer

Ganz

Stanton

2015

Advances in Experimental Medicine and Biology

View full text Add to dashboard Cite

Although prevalence estimates are imprecise, growing numbers of women in the United States are living longer with metastatic breast cancer, attributable at least in part to the availability of effective targeted therapies. Women living with metastatic disease are understudied, however, and substantial heterogeneity exists in both the clinical characteristics of metastatic tumors and the physical and psychological experience of patients living with the disease. Survivorship issues are complex for patients who are living with metastatic disease over extended periods of time, from years to decades. Newly diagnosed patients with stage IV disease are confronting cancer for the first time, while others have metastatic disease as a result of breast cancer recurrence. Many patients are able to live for years on stable medical regimens, and yet others live with a moving target of aggressive disease with arduous treatments and uneven response. The psychological common denominator is the experience of profound life threat and the accompanying uncertainty, for both the affected woman and her loved ones. Maintaining life balance in the face of metastatic disease, as well as managing pain, fatigue, and other physical and psychological symptoms are major challenges. Increasingly, the clinical approach to metastatic disease reflects the consensus that palliative and supportive care are essential from the point of diagnosis. To remedy the paucity of systematic research on women living with metastatic breast cancer for extended periods, we offer directions for research to understand the experience of metastatic breast cancer and to provide evidence-based inter-professional care.

show abstract

A Pan-Canadian Practice Guideline and Algorithm: Screening, Assessment, and Supportive Care of Adults with Cancer-Related Fatigue

Cited by 165 publications

References 46 publications

Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment

Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment

Kronisk tretthet hos voksne kreftoverlevere

Living with Metastatic Breast Cancer

Contact Info

Product

Resources

About